Hideko Yamauchi
Overview
Explore the profile of Hideko Yamauchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
1126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamamoto T, Takahashi A, Yoshizumi T, Ishihara S, Inomata M, Imoto S, et al.
Surg Today
. 2025 Jan;
55(3):295-334.
PMID: 39820660
No abstract available.
2.
Ushigusa T, Hirakawa N, Kajiura Y, Yoshida A, Yamauchi H, Kanomata N
Breast Cancer
. 2024 Dec;
32(2):357-368.
PMID: 39729292
Background: Triple-negative breast cancer (TNBC) is a serious disease with limited treatment options. We explored the significance of androgen receptor (AR) expression and tumor-infiltrating lymphocytes (TILs) in predicting neoadjuvant chemotherapy...
3.
Hirose T, Ikegami M, Kida K, Ueno T, Kitada R, Wang L, et al.
NPJ Breast Cancer
. 2024 Oct;
10(1):87.
PMID: 39366967
Patients with germline pathogenic variants of BRCA1/2 genes have a particular predisposition to develop breast cancer. No clinical test has been developed to accurately and quantitatively evaluate their risk of...
4.
Takehara Y, Tsunoda H, Takei J, Kida K, Yamauchi H, Yagishita K, et al.
BMC Womens Health
. 2024 Sep;
24(1):530.
PMID: 39334023
Background: This study aimed to assess the recognition and understanding of breast awareness (BA) among hospital staff, a group considered influential in disseminating information about health. Compared to the traditional...
5.
Nagura N, Kida K, Yumura C, Yamauchi H
Plast Reconstr Surg Glob Open
. 2024 Sep;
12(9):e6113.
PMID: 39228418
When a delayed seroma with a low volume is detected more than 1 year after silicone breast implant insertion, aspiration is necessary. However, if the seroma is small and difficult...
6.
Nozaki F, Nakanishi Y, Tanino T, Ochi T, In R, Kajiura Y, et al.
Pathol Int
. 2024 Aug;
74(10):592-603.
PMID: 39193980
Pregnancy-associated breast cancer has been increasing. In this study, we analyzed patients with breast cancer that occurred during pregnancy (PrBC) and compared their genetic profiles with those of patients with...
7.
Takahashi S, Sato N, Kaneko K, Masuda N, Kawai M, Hirakawa H, et al.
Transl Oncol
. 2024 Jul;
48:102060.
PMID: 39047382
The TP53 signature is considered a predictor of neoadjuvant chemotherapy (NAC) response and prognostic factor in breast cancer. The objective of this study was to confirm TP53 signature can predict...
8.
Yoshida R, Kaneyasu T, Ueki A, Yamauchi H, Ohsumi S, Ohno S, et al.
Breast Cancer
. 2024 Jul;
31(6):1028-1036.
PMID: 39003386
Background: Tailored, preventive cancer care requires the identification of pathogenic germline variants (PGVs) among potentially at-risk blood relatives (BRs). Cascade testing is carried out for BRs of probands who are...
9.
Ganz P, Bandos H, Spanic T, Friedman S, Muller V, Kuemmel S, et al.
J Clin Oncol
. 2024 Feb;
42(11):1288-1300.
PMID: 38301187
Purpose: The OlympiA randomized phase III trial compared 1 year of olaparib (OL) or placebo (PL) as adjuvant therapy in patients with germline , high-risk human epidermal growth factor receptor...
10.
Lee M, Kotake R, Yamauchi H
Cancer Epidemiol Biomarkers Prev
. 2023 Dec;
33(3):365-370.
PMID: 38147061
Background: Dense breast is one of the strong risk factors for breast cancer among women. While it has been established that physical activity is associated with decreased risk for breast...